Electra Therapeutics, Inc. (ETRA) Ownership
ETRA ownership summary
as of October 18, 2026- Institutions
- 26.9% of shares outstanding
- Insiders
- 1.37% of shares outstanding
- Shares outstanding
- 62.8M
- Float
- 29.1M shares available to trade
- Short interest
- — 702K shares short
- Days to cover
- 0.61
- Institutions 26.90%
- Insiders 1.37%
- Other investors 71.73%
ETRA top mutual fund and ETF holders
2 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | T. Rowe Price Health Care ETF | 0.01% | 5,282 | $46,218 | — | September 30, 2026 |
| 2 | GlobalAccess US Sm & Md Cp Eq M Dis GBP | <0.01% | 600 | $5,250 | +600 (0.0%) | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
Who owns ETRA
Institutional investors own 26.9% of Electra Therapeutics's shares and insiders 1.37%.
Related: ETRA analyst forecast, ETRA key metrics. See the ETRA stock overview for the latest quote and news.
ETRA ownership FAQ
What percentage of Electra Therapeutics is owned by institutions?
Institutions hold 26.9% of Electra Therapeutics's shares outstanding; insiders hold 1.37%.
Which funds own Electra Therapeutics?
The largest fund holders of Electra Therapeutics are T. Rowe Price Health Care ETF (0.01%), GlobalAccess US Sm & Md Cp Eq M Dis GBP (<0.01%).
How many shares of Electra Therapeutics are outstanding?
Electra Therapeutics has 62.8M shares outstanding, of which 29.1M are in the public float.